Nuvectis Pharma, Inc. (NVCT) Form 10-Q Quarterly Reports
Nuvectis Pharma, Inc. (NVCT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NVCT
CIK: 1875558
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerUriel Vider
Audit LocationTel-Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-08-28 | — | EFFECT Filing | 9999999995-26-002815 | View SEC Doc Filr Page |
| S-3 | 2026-08-21 | — | FORM S-3 | 0001104659-26-099717 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-07-20 | FORM 8-K | 0001104659-26-099712 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0001213900-26-085988 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | OWNERSHIP DOCUMENT | 0001104659-26-091279 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001104659-26-090109 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | FORM 8-K | 0001104659-26-090094 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | OWNERSHIP DOCUMENT | 0001104659-26-079793 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | OWNERSHIP DOCUMENT | 0001104659-26-079792 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-29 | FORM 8-K | 0001104659-26-079360 | View SEC Doc Filr Page |
| 424B5 | 2026-06-30 | — | 424B5 | 0001104659-26-079359 | View SEC Doc Filr Page |
| 424B5 | 2026-06-29 | — | 424B5 | 0001104659-26-078864 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | FORM 8-K | 0001104659-26-078823 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-22 | FORM 8-K | 0001104659-26-076624 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073461 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073460 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073459 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073455 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | FORM 8-K | 0001104659-26-073419 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001104659-26-055318 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | FORM 8-K | 0001104659-26-055264 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001104659-26-049480 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-11 | DEF 14A | 0001104659-26-049476 | View SEC Doc Filr Page |
| EFFECT | 2026-02-20 | — | EFFECT Filing | 9999999995-26-000644 | View SEC Doc Filr Page |
| CORRESP | 2026-02-18 | — | CORRESP Filing | 0001104659-26-017097 | View SEC Doc Filr Page |